Healthcare Providers and Services
Company Overview of Alliance Healthcare Deutschland AG
Alliance Healthcare Deutschland AG engages in the wholesale trade of pharmaceutical products to pharmacies and hospitals in Germany and internationally. The company also offers logistics concepts and services for healthcare and pharmaceutical industries; engages in the design and implementation of integrated marketing, distribution, and logistics services for suppliers of health, cosmetics, and care products; and provides inventory and accounting, warehousing and distribution, complaint processing, return management, and hotline services. In addition, it provides market research services to the pharmaceutical manufacturers, pharmaceutical wholesale trade customers, and information service pr...
Frankfurt am Main, 60486
Key Executives for Alliance Healthcare Deutschland AG
Chairman of the Executive Board and Chairman of Executive Committee
Head of Account System & Finances and Member of Executive Committee
Personnel & Operations Director
Member of The Executive Board and Labour Relations Director
Commerce & Services Director
Compensation as of Fiscal Year 2014.
Alliance Healthcare Deutschland AG Key Developments
Andreae-Noris Zahn AG Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2012
Feb 16 13
Andreae-Noris Zahn AG reported consolidated earnings results for the nine months ended December 31, 2012. Sales revenues increased against the comparative prior year period by EUR 10.0 million or 0.3% from EUR 3,317.3 million to EUR 3,327.3 million. Lower other operating income, which was impacted comparatively by the release of valuation allowances in the prior year lower personnel expenses, as well as lower other operating expenses due to cost savings, resulted in earnings before interest and taxes (EBIT) of EUR 46.0 million which were EUR 20.9 million above the result of the comparative prior year period of EUR 25.1 million. However, the impact of restructuring costs in the prior year must be taken into account in this comparison. The financial result improved from loss of EUR 20.4 million to loss of EUR 11.2 million. This is attributable to a decline in interest expenses in connection with the refinancing of the KfW loan and the repayment of the promissory note loans, as well as lower dividend payments to minority shareholders with put options. Overall, earnings before taxes (EBT) rose by EUR 30.1 million from EUR 4.7 million to EUR 34.8 million. With tax expenses of EUR 9.3 million, the consolidated profit increased by EUR 22.2 million to EUR 25.5 million against EUR 3.3 million last year. The earnings per share (both diluted and undiluted) amounted to EUR 2.39 compared with EUR 0.32 during the prior year period. In accordance with the requirements of IAS 8.29, the adjustment in reporting has had an effect on the corresponding comparative period insofar as the cash flow from operating activities improved by EUR 9.6 million to cash used in operating activities of EUR 53.3 million. Mainly due to seasonally higher inventories, the cash used in operating activities amounted to EUR 13.4 million against EUR 53.3 million last year. The cash flow used in investment activities amounted to EUR 6.8 million against EUR 11.0 million last year. This related primarily to investments in buildings and the car fleet.
Andreae-Noris Zahn AG, Special/Extraordinary Shareholders Meeting, Dec 18, 2012
Oct 27 12
Andreae-Noris Zahn AG, Special/Extraordinary Shareholders Meeting, Dec 18, 2012.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries